A win for Pfizer with PBAC confirming the company has met the requirements of the XALKORI (crizotinib) managed entry scheme. Yet doubts remain over the future of the program designed to ensure faster patient access to new medicines. …
Latest Video
New Stories
-
‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer
April 29, 2025 - - Latest News -
These system-shifting therapies come along every few years, but this is different
April 29, 2025 - - Latest News -
Culture review delivers a scathing assessment of New Zealand's Pharmac
April 29, 2025 - - Latest News -
Pfizer-commissioned survey reveals rising GP concerns over medical misinformation
April 29, 2025 - - Latest News -
New survey confirms significant interest in accessing weight loss therapies
April 28, 2025 - - Latest News -
Medicines Australia announces appointment of communications director
April 28, 2025 - - Latest News -
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - - Australian Biotech